// App-Quantinova.ai

e14045 : Role of the expression of PD-L1 and CD47 on circulating tumor cells (CTCs) in the prediction of outcome in metastatic breast cancer (mBC) patients.

Researchers

Presenter

  • Sofia Agelaki

Principal Investigators

  • Maria A. Papadaki

  • Panormitis G Tsoulfas

  • Despoina Aggouraki

  • Alexia A Monastirioti

  • Katerina A Merodoulaki

  • Konstantina Thomopoulou

  • Chara Papadaki

  • Dimitrios Mavroudis

Medical Centers

  • Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • Cluster of Differentiation 47

  • Programmed death-ligand 1

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved